Oxford Biomedica Uk competitive analysis

Explore patent oppositions filed by Oxford Biomedica Uk against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Jan 29, 2026
Patent NumberTitleApplicantOpposition Date
Trophoblast Glycoprotein (5T4, Tpbg) Specific Chimeric Antigen Receptors For Cancer ImmunotherapyCELLECTISSep 24, 2020
Scalable Lentiviral Vector Production System Compatible With Industrial Pharmaceutical ApplicationsGENETHONOct 4, 2018

Latest PTAB cases involving Oxford Biomedica Uk

Discover the latest PTAB cases involving Oxford Biomedica Uk, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Oxford Biomedica Uk with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Jan 29, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
OXFORD BIOMEDICA UK2 - - -
CELLECTIS - 21 - -
GENETHON - 19 - -